Bevacizumab in patients with previously treated metastatic colorectal cancer: preliminary results of a phase II study (bevacolor)

被引：0
作者：
Borg, C. [1 ]
Delord, J. P. [2 ]
Husseini, F. [3 ]
Lenoir, V. Trillet [4 ]
Faroux, R.
Francois, E. [5 ]
Ychou, M. [6 ]
Bergougnoux, L. [7 ]
Bennouna, J. [8 ]
Douillard, J. Y. [8 ]
机构：
[1] CHU Besancon, INSERM, U 645, Toulouse, France
[2] Inst Claudius Regaud, Toulouse, France
[3] Hop Louis Pasteur, Colmar, France
[4] Ctr Hosp Lyon Sud, Lyon, France
[5] Ctr Antoine Lacassagne, F-06054 Nice, France
[6] CHRU, Montpellier, France
[7] Dept Stat, Neuilly sur Seine, France
[8] Ctr Rene Gauducheau, F-44035 Nantes, France
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70998-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3070
引用
收藏
页码：257 / 257
页数：1
相关论文
共 50 条
  • [41] 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plua bevacizumab in patients with metastatic colorectal cancer: Preliminary results of a multicenter phase II trial
    Cordio, S.
    Condorelli, S.
    Rosati, G.
    Soto-Parra, H.
    Caputo, G.
    Rampello, E.
    Salice, P.
    Rimassa, L.
    Pumo, V
    Manzione, L.
    Bordonaro, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 99 - 99
  • [42] A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer
    Cobleigh, MA
    Langmuir, VK
    Sledge, GW
    Miller, KD
    Haney, L
    Novotny, WF
    Reimann, JD
    Vassel, A
    SEMINARS IN ONCOLOGY, 2003, 30 (05) : 117 - 124
  • [43] Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer
    Kemeny, N
    Tong, W
    Gonen, M
    Stockman, J
    Di Lauro, C
    Teitcher, J
    White, P
    Price, C
    Saltz, L
    Sharma, S
    Graham, MA
    ANNALS OF ONCOLOGY, 2002, 13 (09) : 1490 - 1496
  • [44] A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer
    Yoshino, Takayuki
    Yamazaki, Kentaro
    Yamaguchi, Kensei
    Doi, Toshihiko
    Boku, Narikazu
    Machida, Nozomu
    Onozawa, Yusuke
    Asayama, Masako
    Fujino, Tadahiro
    Ohtsu, Atsushi
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) : 910 - 917
  • [45] A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer
    Takayuki Yoshino
    Kentaro Yamazaki
    Kensei Yamaguchi
    Toshihiko Doi
    Narikazu Boku
    Nozomu Machida
    Yusuke Onozawa
    Masako Asayama
    Tadahiro Fujino
    Atsushi Ohtsu
    Investigational New Drugs, 2013, 31 : 910 - 917
  • [46] Phase II trial of bevacizumab and everolimus in the treatment of patients with metastatic melanoma: Preliminary results
    Peyton, J. D.
    Spigel, D. R.
    Burris, H. A.
    Lane, C.
    Rubin, M.
    Browning, M.
    Trent, D.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study
    Morganti, Alessio G.
    Mignogna, Samantha
    Caravatta, Luciana
    Deodato, Francesco
    Macchia, Gabriella
    Plantamura, Nunzio M.
    Massaccesi, Mariangela
    Picardi, Vincenzo
    Cilla, Savino
    Valentini, Vincenzo
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (06) : 353 - 358
  • [48] Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study
    Xu, Rui-Hua
    Li, Jin
    Bai, Yuxian
    Xu, Jianming
    Liu, Tianshu
    Shen, Lin
    Wang, Liwei
    Pan, Hongming
    Cao, Junning
    Zhang, Dongsheng
    Fan, Songhua
    Hua, Ye
    Su, Weiguo
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10 : 1 - 8
  • [49] Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study
    Rui-Hua Xu
    Jin Li
    Yuxian Bai
    Jianming Xu
    Tianshu Liu
    Lin Shen
    Liwei Wang
    Hongming Pan
    Junning Cao
    Dongsheng Zhang
    Songhua Fan
    Ye Hua
    Weiguo Su
    Journal of Hematology & Oncology, 10
  • [50] Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer
    Meyerhardt, JA
    Zhu, AX
    Enzinger, PC
    Ryan, DP
    Clark, JW
    Kulke, MH
    Earle, CC
    Vincitore, M
    Michelini, A
    Sheehan, S
    Fuchs, CS
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) : 1892 - 1897
12345